Effective single dose therapy for vaginal candidiasis

Miconazole has long been accepted as therapy for vaginal candidiasIs, but multiple doses have been recommended. Single dose vaginal therapy with mlconazole 1200mg In an ovule formulation had a cure rate of 87.8% and a mycological recurrence rate of 161 % when administered to 42 evaluable patients with acute vaginal candidiasis. All patients considered the preparation easy to use. One patient experienced 'burning pain' shortly after ovule insertion Dinsmore WW, Graner SE. An open study to assess the acceptability and effectiveness of mlconazole 1,200mg single ovule In the treatment of acute vaginal candldosis. Bntish Journal of Clinical Practice 43 238-241, Jul 1989 0080

0156-2703/89/0826-0013/0$01.00/0 © ADIS Press INPHARMA' 26 Aug 1989 13